PharmaTher Holdings Ltd.
PHRRF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $2 | $3 | $3 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $4 | $4 |
| Operating Income | -$2 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$2 | -$0 |
| Pre-Tax Income | -$2 | -$3 | -$6 | -$4 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$2 | -$3 | -$6 | -$4 |
| % Margin | – | – | – | – |
| EPS | -0.017 | -0.035 | -0.073 | -0.049 |
| % Growth | 51.3% | 51.5% | -47.4% | – |
| EPS Diluted | -0.02 | -0.035 | -0.073 | -0.049 |
| Weighted Avg Shares Out | 76 | 88 | 88 | 81 |
| Weighted Avg Shares Out Dil | 89 | 88 | 88 | 81 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |